Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event

Equillium (Nasdaq: EQ) announced that management will present at Oppenheimer’s 2026 Innovation on the Island event on Tuesday, April 28, 2026 at 7:50am AST.

Rhea-AI Summary

Equillium (Nasdaq: EQ) announced that management will present at Oppenheimer’s 2026 Innovation on the Island event on Tuesday, April 28, 2026 at 7:50am AST.

Members of management will be available for investor meetings for registered attendees, providing an opportunity for investor engagement and company updates.

Argus Apr 21 session

+6.97% close to close Open Argus

Details

News Market Reaction – EQ

On Apr 21, the first trading day after this news, EQ closed 6.97% above the previous close.

Data tracked by StockTitan Argus for the Apr 21 session.

Key Figures

Conference presentation time: 7:50am AST

Conference presentation time

7:50am AST

Oppenheimer’s 2026 Innovation on the Island Event on April 28, 2026

Historical Context

5 past events · Latest: Apr 08

5 events

1. Apr 08

   Preclinical poster data

   24h Move

   -6.3%

   IMMUNOLOGY2026 EQ504 preclinical immune tolerance and barrier repair posters.

2. Apr 02

   Inducement option grant

   24h Move

   +2.0%

   Inducement stock option for 32,000 shares at $2.04 to new employee.

3. Mar 25

   Earnings & pipeline update

   24h Move

   +0.0%

   2025 results with no revenue, $22.4M net loss and EQ504 plans.

4. Mar 18

   Roth conference participation

   24h Move

   -0.9%

   Management fireside chat and investor meetings at Roth conference.

5. Mar 13

   PIPE financing

   24h Move

   +19.3%

   $35M PIPE with RA Capital to fund EQ504 and extend cash runway.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LA JOLLA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will be presenting at Oppenheimer’s 2026 Innovation on the Island Event on Tuesday April 28, 2026 at 7:50am AST.

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

About Equillium
Equillium is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders. The company’s lead therapeutic candidate is EQ504, a potent and selective aryl hydrocarbon receptor (AhR) modulator designed with a multi-modal, non-immunosuppressive mechanism of action to be complementary to other inflammation and immunology agents. EQ504 is an investigational therapeutic program with potential for targeted, local delivery via enteric coating for the treatment of ulcerative colitis and other gastrointestinal diseases or inhaled formulations for the treatment of inflammatory lung diseases.

For more information, visit www.equilliumbio.com.

Investor Contact 
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Equillium (EQ) present at Oppenheimer’s 2026 Innovation on the Island event?

Equillium will present on Tuesday, April 28, 2026 at 7:50am AST. According to Equillium, management scheduled the presentation for that date and time as part of Oppenheimer’s investor event agenda, allowing prepared remarks and potential investor Q&A during the session.

How can investors meet Equillium management at the April 28, 2026 event?

Registered investors can request meetings with Equillium management at the conference. According to Equillium, members of the management team will be available to meet with investors who are registered to attend, subject to event scheduling and registration procedures.

What topics will Equillium (EQ) likely cover during the April 28, 2026 presentation?

The presentation will cover recent company developments and strategic updates for investors. According to Equillium, management intends to present company progress and engage with attendees, focusing on therapeutic programs and investor-relevant developments without providing specific new financial data.

Is the Equillium presentation at Oppenheimer’s event open to the public or only registered investors?

The presentation and investor meetings are available to registered conference attendees only. According to Equillium, management will meet with investors who are registered to attend the Oppenheimer event, so access requires event registration and any organizer rules for attendance.

Where can investors find Equillium’s presentation details for April 28, 2026 after the event?

Presentation materials may be posted after the event on Equillium’s investor channels. According to Equillium, investors should check company investor relations resources for any slides, summaries, or recordings that the company elects to make available following the conference.